Serena Williams Says This Weight-Loss Drug Did for Her What Tennis Never Could - harpersbazaar.com
Harpersbazaar.comarrow_outward‘Ozempic For All’ is starting to make economic sense - The Washington Post
The Washington Postarrow_outwardSerena Williams Reveals She Lost 31 Pounds With Weight Loss Medication - Katie Couric Media
Katie Couric Mediaarrow_outwardSerena Williams reveals she uses GLP-1 weight loss drug Zepbound: 'I just could never get back to where I needed to be’ - yahoo.com
Yahoo.comarrow_outwardHealth Rounds: GLP-1 drugs linked to lower cancer risks - TradingView
TradingViewarrow_outwardSerena Williams says the use of GLP-1 drugs like Ozempic and Zepbound is not shortcut - TheGrio
TheGrioarrow_outwardSerena Williams: I used weight loss drug after having children - The Times
The Timesarrow_outwardWeight-loss drugs could reduce the risk of cancer developing in obese people - EL PAÍS English
EL PAÍS Englisharrow_outwardSerena Williams to promote weight-loss drugs with telehealth firm Ro - The Straits Times
The Straits Timesarrow_outwardExperts say exercise is critical for GLP-1 users' muscles - KVUE
KVUEarrow_outwardSerena Williams Reveals Her Choice to Use GLP-1 for Weight Loss: "I Tried..." - NBC
NBCarrow_outwardSerena Williams shares her journey using GLP-1 treatments to lose weight - HOLA
HOLAarrow_outward'I feel normal again': Serena Williams shares her story of 31-pound weight loss with GLP-1 medication - WION
WIONarrow_outwardSerena Williams Loses 31 Pounds Using GLP-1 Medication - E! Online
E! Onlinearrow_outwardExclusive: Serena Williams opens up about her weight-loss journey on a GLP-1 - Women's Health
Women's Healtharrow_outwardWhat are GLP-1s? All on medication Serena Williams used to shed 30 lbs | Trending - Hindustan Times - Hindustan Times
Hindustan Timesarrow_outwardGLP-1 Market Volatility and Novo Nordisk's Strategic Risks: A Governance and Legal Crossroads - AInvest
AInvestarrow_outwardGood News on GLP-1s and Cancer Risk, With One Exception - MedPage Today
MedPage Todayarrow_outward‘I don’t take shortcuts’: Serena Williams reveals what is behind recent weight loss - FOX 8 News
FOX 8 Newsarrow_outwardSerena Williams Reveals the Weight-Loss Treatment That Changed Everything - bet.com
Bet.comarrow_outward“Ozempic face” is aging GLP-1 patients before their time. These new skin care products claim to help. - Slate Magazine
Slate Magazinearrow_outwardSerena Williams feels ‘light physically and mentally’ after losing 31 pounds with weight loss medication - Yahoo Lifestyle Canada
Yahoo Lifestyle Canadaarrow_outwardSerena Williams reveals GLP-1 weight loss in partnership with healthcare company Ro - USA Today
USA Todayarrow_outwardSerena Williams Gets Real About Using Weight Loss Medication to Lose 31 Pounds - instyle.com
Instyle.comarrow_outwardSerena Williams stuns fans with surprising weight loss admission - sportingnews.com
Sportingnews.comarrow_outwardSerena Williams reveals she's using weight loss drugs and addresses stigma: "You're not taking a shortcut" - CBS News
CBS Newsarrow_outwardTennis legend Serena Williams reveals she lost over 30 pounds after taking weight-loss drug - Yahoo Sports
Yahoo Sportsarrow_outwardSerena Williams Opens Up About GLP-1 Weight Loss in New Ro Ad - Bloomberg.com
Bloomberg.comarrow_outwardSerena Williams Lost 31 Pounds With GLP-1 Drug: EXCLUSIVE
TODAY.comarrow_outwardSerena Williams reveals she's taking weight loss medication: 'I don't take shortcuts'
NBC Newsarrow_outwardSerena Williams Opens Up About GLP-1 Weight Loss in New Ro Ad
Bloombergarrow_outwardSERENA WILLIAMS JOINS RO AS GLP-1 CELEBRITY AMBASSADOR - PR Newswire
PR Newswirearrow_outwardSerena Williams Is the Surprising New Face of Weight-Loss Drugs - The Wall Street Journal
The Wall Street Journalarrow_outwardSerena Williams Opens Up About Being on a GLP-1 - Vogue
Voguearrow_outwardNonmechanical Small Bowel Obstruction in a Patient on Zepbound Without a Surgical History: A Case Report - Cureus
Cureusarrow_outwardGLP-1 RAs May Top Metformin in Lowering T2D Dementia Risk - Medscape
Medscapearrow_outwardLiver Lineup: GLP-1 RAs and FGF21s for MASH, with Mary Rinella, MD - HCP Live
HCP Livearrow_outwardCan You Use GLP-1 Medications for Menopause Weight Gain? - Healthline
Healthlinearrow_outwardLow FODMAP diet increases GLP-1 and relieves IBS symptoms - News-Medical
News-Medicalarrow_outwardWhat makes GLP1 receptor agonist drugs so effective for obesity? - Open Access Government
Open Access Governmentarrow_outwardGLP1-RA wins expanded approval for diabetics with CKD - Medical Republic
Medical Republicarrow_outwardUnderstanding the risk of diabetic retinopathy from glucagon-like peptide-1 receptor agonists: a Mendelian randomization study and systematic review of European populations - Diabetology & Metabolic Syndrome
Diabetology & Metabolic Syndromearrow_outwardPentagon Drops Coverage of GLP-1 Weight Loss Meds for Medicare-Eligible Retirees - Military.com
Military.comarrow_outwardGLP-1 drugs and vision loss: How significant are the risks? - Medical News Today
Medical News Todayarrow_outwardWhat you need to know about the compounded GLP-1 ban - Nebraska Medicine
Nebraska Medicinearrow_outwardThe role of dietary supplements in supporting GLP-1 users - SupplySide Supplement Journal
SupplySide Supplement Journalarrow_outwardViking’s GLP-1 Pill Results Mixed, Shares Slump - The Business of Fashion
The Business of Fashionarrow_outwardGLP-1 boom puts medispas under regulatory scrutiny, insurance pressure - Insurance Business America
Insurance Business Americaarrow_outwardWhat makes a GLP-1-friendly yogurt drink? Danone tells all - DairyReporter.com
DairyReporter.comarrow_outwardGLP-1 users are undernourished: why F&B needs to fill the gap - FoodNavigator.com
FoodNavigator.comarrow_outwardTaking GLP-1s for weight loss? Here’s why strength training is key - CNN
CNNarrow_outwardGLP-1 drugs linked to reduced symptoms in chronic skin condition hidradenitis suppurativa - Medical Xpress
Medical Xpressarrow_outwardNovo’s Wegovy becomes first GLP-1 drug approved for MASH - BioPharma Dive
BioPharma Divearrow_outwardA Shot at a Healthier Future: The Transformative Potential of GLP-1s - Information Technology and Innovation Foundation (ITIF)
Information Technology and Innovation Foundation (ITIF)arrow_outwardThe challenge of developing oral alternatives to peptide weight loss drugs - Chemistry World
Chemistry Worldarrow_outwardLilly's oral GLP-1, orforglipron, delivers weight loss of up to an average of 27.3 lbs in first of two pivotal Phase 3 trials in adults with obesity | Eli Lilly and Company - Eli Lilly and Company
Eli Lilly and Companyarrow_outwardEfficacy and safety of GLP-1 agonists in the treatment of T2DM: A systematic review and network meta-analysis - Nature
Naturearrow_outwardOptic Neuropathy and Other Hidden Ocular Risks of GLP-1 RA Weight Loss Drugs - Neurology Advisor
Neurology Advisorarrow_outwardA new era of weight loss: Mental health effects of GLP-1 drugs - American Psychological Association (APA)
American Psychological Association (APA)arrow_outwardnewsGP - Is the first GLP-1 pill around the corner? - Royal Australian College of General Practitioners (RACGP)
Royal Australian College of General Practitioners (RACGP)arrow_outwardEfficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet
The Lancetarrow_outwardNutritional priorities to support GLP-1 therapy for obesity: A joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society - Wiley Online Library
Wiley Online Libraryarrow_outwardWhat and how you eat can increase the effects of GLP-1 without drugs - The Conversation
The Conversationarrow_outwardHow just a fishing expedition helped lead to GLP-1 - Harvard Gazette
Harvard Gazettearrow_outwardCould drugs like Ozempic also benefit people with type 1 diabetes? - Breakthrough T1D
Breakthrough T1Darrow_outwardEstrogenic activity of E2-conjugated GLP-1 is mediated by intracellular endolysosomal acidification and estrone metabolism - ScienceDirect.com
ScienceDirect.comarrow_outwardAustralia GLP-1 Receptor Agonist Market Size to Hit USD 1,899.62 Million by 2034 - Precedence Research
Precedence Researcharrow_outwardHow Ozempic blunts food cravings — and our hankering for salty and sweet - Australian Broadcasting Corporation
Australian Broadcasting Corporationarrow_outwardAdvances in GLP-1 receptor agonists for pain treatment and their future potential - The Journal of Headache and Pain
The Journal of Headache and Painarrow_outwardPredicting responsiveness to GLP-1 pathway drugs using real-world data - BMC Endocrine Disorders
BMC Endocrine Disordersarrow_outward
Glp-1 close
- 2025-08-21 21:00 event
- 70 sourceslanguage
- 200+ ads_click
- 5 days ago schedule